Wednesday, Apr 21, 2021 - 19:01:36
23 results - (0.001 seconds)

the other vaccines:

latest news at page 1:
1
    Stock markets point to a positive start in Europe this Tuesday, encouraged by the German CPI reading which has come out higher than expected in March, which fuels expectations for the eurozone price data to be published on Wednesday. The Ibex will look for rises above 8,500 points, until the resistance that rests in the 8,624 points highs of the bearish gap of a week ago. If it were to overcome this resistance, it is likely that we could end up seeing a spread of winnings up to the 9,000 point level“, says César Nuez, an analyst at Bolsamanía. Investors’ attention will continue on the news that may arrive from the MásMóvil takeover bid for Euskaltel, which shows its effect on Telefónica, the worst of the selective this Monday, with falls of almost 4%. At the business level, it is also news Cellnex, which has announced an issue of...
    Unvaccinated American children will need to continue to wear masks if they ‘interact with groups from other households,’ Dr. Anthony Fauci said on Sunday. The nation’s top infectious disease expert said that it is ‘conceivable’ parents will be able to send their kids to playgrounds and summer camps so long as mass vaccination continues at the same pace. ‘We now have three to 3.5 million vaccinations each day,’ Fauci, who is President Biden's chief medical adviser, told CBS News’ Face the Nation. ‘If we keep up at that pace, invariably that’s going to drive the rate and the level of infections per day to a much, much lower level. FAUCI COMMENTS ABOUT CHILDREN START AT 2:50  Dr. Anthony Fauci, the nation's top infectious disease expert, said children should continue to wear masks while playing with other kids 'from different households' ‘If we get into the summer, and you...
    London (CNN Business)After teaming up with Oxford University, AstraZeneca produced a safe and effective Covid-19 vaccine in just nine months, a huge achievement that will help end the pandemic. But a series of missteps along the way has led to scathing criticism from policymakers and health officials, tarnishing the company's image as a hero of the coronavirus era.The Anglo-Swedish drugmaker mistakenly gave some volunteers a half dose of the vaccine during clinical trials, and it has been criticized for omitting crucial information from its public statements. US regulators have questioned the accuracy of its vaccine data, and severe production delays in Europe have resulted in a political firestorm and a breakdown in relations with EU leaders."What we have with AstraZeneca is a company that is not straightforward, that cannot be relied upon," Philippe Lamberts, a Belgian member of the European Parliament, said in a radio interview with the BBC on...
    (CNN)With Covid-19 vaccination production and distribution ramping up in the United States, more states are expanding who is eligible to be inoculated.On Tuesday, Mississippi is following Alaska's lead and becoming the second state to open vaccination appointments to all residents 16 years and older, Gov. Tate Reeves said Monday."Starting tomorrow, ALL new appointments will be open to ALL Mississippians. Get your shot friends - and let's get back to normal!" he tweeted Monday. Officials are racing to get Americans vaccinated and manage the pandemic before variants can dominate the cases spreading around the country.President Joe Biden has called for all American adults to be eligible for vaccines by May 1, but some are planning to expand who can be inoculated earlier. Read MoreHere is where each state stands:AlabamaBeginning March 22, all residents 55 and older, people with intellectual and developmental disabilities, critical workers and people with high-risk medical conditions will...
    A New England Medical Journal (NEJM) study is the latest in a slew of research to show that one dose of a coronavirus vaccine gives COVID-19  survivors as much protection as two doses offer people who have never been infected.  'These findings suggest that a single dose of vaccine elicits a very rapid immune response in individuals who have tested positive for COVID-19,' said study co-author and renowned Mount Sinai vaccinologist Dr Florian Krammer.  'In fact, that first dose immunologically resembles the booster (second) dose in people who have not been infected.'  But Dr Anthony Fauci and U.S. health officials have been insistent that everyone get two doses of vaccines made by Moderna and Pfizer.  So why not give people who have had COVID-19 just one shot, instead of two?  An expert told DailyMail.com that now that the U.S. has more vaccine dose available from three manufacturers, the process of...
    By Ganesh Setty | CNN Detroit Mayor Mike Duggan declined an initial allocation of the newly authorized Johnson & Johnson Covid-19 vaccine this week even as nationwide demand continues to outpace available supply. Duggan, a Democrat who has been mayor since 2014, said he turned down the shipment because the city is able to meet current demand with its supply of the Pfizer/BioNTech and Moderna vaccines — even as his administration expanded vaccine eligibility Thursday to residents ages 50 and older with chronic medical conditions. “So, Johnson & Johnson is a very good vaccine. Moderna and Pfizer are the best. And I am going to do everything I can to make sure the residents of the City of Detroit get the best,” Duggan said during a news conference Thursday. The US Food and Drug Administration on Saturday authorized the one-dose J&J vaccine, which was found to be 72% effective in...
    PITTSBURGH (KDKA) — The Johnson & Johnson vaccine is now the third coronavirus vaccine in the U.S. authorized under emergency use. “This should really help with distribution and getting closer to the end of the pandemic,” says Allegheny Health Network infectious diseases physician Dr. Matthew Moffa. READ MORE: COVID-19 In Pennsylvania: Lack Of Vaccine Supply Forces St. Clair Hospital To Cancel First Dose Appointments It is different from Pfizer’s and Moderna’s vaccines. For instance, J&J’s is not an mRNA vaccine. “It’s something called a viral vector vaccine,” Dr. Moffa said. “So it takes a harmless virus called adenovirus, inactivated in the lab, and they package it with genetic information.” Genetic information for the coronavirus spike protein, which the body starts to make, spurring the immune system to make antibodies. “If you get exposed in the future to the virus, your body is ready to give you protection,” said Dr. Moffa....
    Two South Carolina residents are the first Americans with the South African 'super covid' variant that may make vaccines less effective, state health department officials confirmed on Thursday.  Neither person has a 'known' recent history of travel and they have no evident connection to one another as far as health officials can tell. That's a worrying signal that the 50 percent more infectious variant has already been spreading silently in South Carolina, if not the broader US.  Dr Anthony Fauci said that he is more concerned about the South African variant than about the UK's B117 'super-covid' because South African form has mutations that might render vaccines less effective. Both Moderna and Pfizer said this week that preliminary lab tests suggest their vaccines are 'protective' against the variant, but it does diminish the effectiveness of their shots.  Each company has said it is developing booster shots to improve the potency...
    Health officials in California are investigating whether a homegrown coronavirus strain could be partly to blame for the state's surge in infections.  According to the Los Angeles Times, scientists stumbled upon the new strain while looking for signs of the highly contagious variant that originated in the United Kingdom before making its way over to the US.  During that search, researchers found a new strain, dubbed B.1.426, which is thought to be responsible for the rapid rise in infections during the holiday season in California where more than 3.1 million cases have been reported and 36,790 people have died.  The new strain is also highly contagious and is propagating faster than any other variant in California. 'While the B.1.1.7 strain may play an important role in increased COVID rates in the UK and Europe, there are still no reports to account for the current spike of cases in Los Angeles and California...
    Move over, Pfizer and Moderna. You won’t be the only games in town too much longer. COVID-19 has existed for barely more than a year, but 64 vaccines are in clinical development and another 173 in preclinical development worldwide nonetheless, according to the World Health Organization. Dozens of hopefuls are in clinical trials in the U.S., including several by California researchers. But the two inching closest to the finish line here — by Oxford-AstraZeneca and Johnson & Johnson — could win emergency use authorization from the U.S. Food and Drug Administration as soon as this spring, which would instantly increase supply and deliver a much-needed jolt to the nation’s maddeningly sluggish mass vaccination campaign. Rocky Mountain Regional VA Medical Center investigational pharmacy technician Sara Berech prepares a dose of the Johnson & Johnson COVID-19 vaccine for a clinical trial on December 15, 2020 in Aurora, Colorado. The Johnson & Johnson...
    United CEO Scott Kirby says he's considering making the COVID-19 vaccine mandatory among staff  United Airlines CEO Scott Kirby has announced he's in favor of a mandatory COVID-19 vaccine policy for all employees and says other companies should follow suit.  Kirby on Thursday spoke during an employee town hall meeting where he informed staff he is strongly considering the move.  'The worst thing that I believe I will ever do in my career is the letters that I have written to the surviving family members of coworkers that we have lost to the coronavirus,' he said, according to a transcript obtained by CNBC.  'And so, for me, because I have confidence in the safety of the vaccine – and I recognize it's controversial – I think the right thing to do is for United Airlines, and for other companies, to require the vaccines and to make them mandatory.'  Legally,...
    On the same day that Donald Trump sent his followers to capture the Capitol and threaten the lives of lawmakers in an attempt to overthrow the nation, COVID-19 killed over 4,000 American in a single day. The 4,100 who were tallied at WorldOMeters by the end of Wednesday was, by far, a new record. That record held all the way until Thursday, when 4,200 died. Thursday also brought 261,000 new cases in a single day, also a new record. As Trump focuses on nothing but encouraging violence and protecting his own fading power, it appears that the federal government is giving zero attention to the crisis that has now killed 375,000 Americans. Nothing is being done to address the inadequate testing. Nothing is being done to provide guidance on the increased need for masks and social distancing. Nothing is being done to address the stumbling efforts to roll out vaccines. Nothing is...
    The chief scientific adviser for Operation Warp Speed said on Wednesday that the frequency of allergic reactions to Pfizer's COVID-19 vaccine is 'superior' to what is typically seen from other vaccines.  Dr. Moncef Slaoui said that the last time he was updated on allergic reactions was on Tuesday, when there were six cases, CNN reported.  'That frequency, as it stood yesterday, is superior to what one would expect with other vaccines,' he said. Dr. Moncef Slaoui said that the last time he was updated on allergic reactions was on Tuesday, when there were six cases of allergic reactions Dr. Slaoui did note that the data on coronavirus immunizations is lagging behind the actual numbers. He added that there are discussions between the vaccine makers and the National Institutes of Health to consider running clinical trials of the vaccines in very allergic populations, ideally those who carry an EpiPen with them....
    NEW YORK (CBSNewYork) — Despite some glitches, two COVID vaccines are now rolling out to high-risk groups across the country. That has led to many questions as people start thinking about getting vaccinated. Our first question comes from CBS2 viewer Mary, who asks, “What’s in the vaccine?” Mary wants to know because she’s very allergic to penicillin. While there have been a tiny number of allergic reactions to the Pfizer vaccine, there is nothing resembling penicillin in either vaccine, CBS2’s Dr. Max Gomez says. Both the Pfizer and Moderna vaccines use a similar, brand-new technology to induce immunity, so people rightly want to know what’s in them. MORE: Should People With Autoimmune Disorders, Like Lupus, Take The Vaccine? Will People Need A Vaccine Shot Every Year? Surprisingly little. There are tiny snippets of what’s called messenger or mRNA. That’s the genetic blueprint the virus uses to make the spike protein...
    (CNN)The US Surgeon General is touting the coronavirus vaccine as "almost 100% certain" to prevent severe disease, part of his effort to reassure the public it's safe to get.As health care workers administer Moderna and Pfizer vaccines, the experts have more information about them than any other in history, Dr. Jerome Adams said at a news conference Saturday."This vaccine is almost 100% certain to prevent you or your loved one from getting severe disease," Adams said. "It is the way we end this pandemic."Both vaccine candidates received emergency use authorizations (EUA) from the US Food and Drug Administration and a recommendation from the US Centers for Disease Control and Prevention. But the race to produce and distribute the vaccine has bred some public skepticism over vaccines against the virus that has infected more than 17.6 million people in the United States and killed 316,176, according to data from Johns Hopkins...
    Prisoners, people in homeless shelters and medical workers will be the first to receive the COVID-19 vaccination in Massachusetts, ahead of the elderly and general public. The state's three-phase distribution plan was laid out on Wednesday and gives priority to healthcare workers, first responders, and those in congregate settings like jails and shelters from December to February.  Phase two from February to April will see individuals at a high risk of COVID-19 complications, school teachers, sanitation and public works employees and adults over the age of 65 receive the vaccine. Under phase three from April to June the vaccine will be available to the general public. Each state will determine their own distribution plans and at least nine states - Massachusetts, Connecticut, Delaware, Maryland, Nebraska, North Carolina, Montana, Nevada, New Mexico - and Puerto Rico will give inmates first access to the vaccine, according to the Washington Post.   Prisons across the...
    Don’t be in any doubt – the development of a highly effective vaccine for Covid-19 in less than a year is an extraordinary scientific achievement, perhaps the greatest of my lifetime. I’d put it on a par with Alexander Fleming’s discovery of penicillin in 1928. It really is that transformative. And that’s because the implications are so much wider than the vaccine’s capacity to halt this pandemic.  Now, as a direct result of this research, new vaccines are on course to protect us from many infectious diseases – including the scourge of antibiotic-resistant bacteria. PROF BRENDAN WREN: The development of a highly effective vaccine for Covid-19 in less than a year is an extraordinary scientific achievement. Handout photo of the coronavirus vaccine being produced  As a result of a battery of the world’s most talented scientists – frequently working in concert, rather than siloed in their own fields –...
    London (CNN)In the days since Oxford University and AstraZeneca unveiled the results of the partnership's Phase 3 Covid-19 vaccine trials, a growing number of questions have emerged. The stated 70% average efficacy was significantly lower than the 94.5% to 95% reported by the other two leading candidates, Moderna and Pfizer.Yet this vaccine could still prove to be more valuable for the world than the other two in the coming months. If the questions over its results are answered and it receives approval, it may lead the way in providing vaccine coverage in poorer countries where it is urgently needed.The UK government took the first step in that approval process on Friday, announcing that it had formally referred the candidate to the UK's medicines regulator for assessment. A researcher in a laboratory at the Jenner Institute in Oxford, England, works on the coronavirus vaccine developed by AstraZeneca and Oxford University."[T]he Pfizer...
    US Surgeon General Dr Jerome Adams has pledged he will get the first coronavirus vaccine approved for emergency use when told it is safe. During an interview on Good Morning America on Monday, Adams was asked about a recent Gallup poll, which found that more than 40 percent of people are unwilling to be immunized against the virus that has killed more than 256,000 Americans.  He said he has been traveling around the country reassuring the public that researchers did not safety corners when developing the jab. '[T]he most reassuring thing I can say to you, America, is that when [the US Food and Drug Administration] tells me that I can get the vaccine, I will get it because I know that's the best way to protect myself and to protect my family and my community,' he said. It comes as AstraZeneca became the latest drug company to report positive...
    THE UK Government has ordered more coronavirus vaccines per capita than any other country in the world - almost a third more than the EU. According to the latest data, Brits are set to have around 5.4 doses each on offer. ⚠️ Read our coronavirus live blog for the latest news & updates 3A scientist working on the Moderna coronavirus vaccineCredit: @ Bearwalk Cinema The Government has pre-ordered 355 million doses in total from six leading pharmaceutical companies developing the drug. And with a population of 66 million, that means there will be about 5.4 doses per person - including children. The EU has ordered around 3.8 doses per capita after countries in the union joined forces to order vaccines, according to data from Deutsche Bank. The UK is leading the charge with orders, with the US, Canada and Japan following closely. Today it emerged Pfizer's Covid vaccine is...
    THE government has ordered 350million doses of Covid-19 vaccine, including 40m of the promising Pfizer shot. Other potential inoculations are at different stages of testing, but it’s hoped the whole UK population - 66.7million people - can eventually receive a vaccine. ⚠️ Read our coronavirus live blog for the latest news & updates 2Deputy chief medical officer, Jonathan Van-Tam, said the Pfizer findings are good news for many other vaccinesCredit: Getty - Pool Clinical testing has three phases, with the number of patients involved increasing with each phase. Jonathan Van-Tam, deputy chief medical officer for England, said the Pfizer vaccine is revolutionary because it attacks Covid-19 directly. Previous vaccines have worked by prompting the body to generate antibodies which then attack the infection. Mr Van-Tam said: “The vaccine targets the S-protein of the coronavirus. Before this, all we knew was that vaccines could give us antibodies, we didn’t know...
    VIDEO2:4902:49Pfizer board member Scott Gottlieb: States will manage distribution of coronavirus vaccineSquawk Box Numerous pharmaceutical companies are racing to complete clinical trials and become the first to successfully get U.S. approval for a vaccine to fight the coronavirus, which has infected more than 50.5 million people worldwide in 11 months. A safe and effective vaccine is seen by investors and policymakers as a solution to get the global economy back on track after the pandemic wreaked havoc on nearly every country across the globe and upended businesses. Phase three trials are the critical last step needed to get the vaccines submitted to the Food and Drug Administration for potential authorization and distribution. Of the 47 vaccines in clinical trials worldwide, there are currently four U.S.-backed frontrunners in phase three: Pfizer, Moderna, AstraZeneca and Johnson & Johnson's. A fifth drugmaker, Novavax, said it expects to begin its late-stage trial in the...
1